Amalgamated Bank’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-128
Closed -$2K 3033
2025
Q1
$2K Hold
128
﹤0.01% 2828
2024
Q4
$5K Hold
128
﹤0.01% 2710
2024
Q3
$4K Hold
128
﹤0.01% 2800
2024
Q2
$11K Buy
128
+16
+14% +$1.73K ﹤0.01% 2380
2024
Q1
$16K Sell
112
-187
-63% -$15.8K ﹤0.01% 2222
2023
Q4
$28K Sell
299
-33
-10% -$3.35K ﹤0.01% 2492
2023
Q3
$55K Hold
332
﹤0.01% 2214
2023
Q2
$21K Hold
332
﹤0.01% 2703
2023
Q1
$11K Sell
332
-84
-20% -$4.39K ﹤0.01% 2790
2022
Q4
$24K Hold
416
﹤0.01% 2700
2022
Q3
$39K Hold
416
﹤0.01% 2561
2022
Q2
$93K Sell
416
-112
-21% -$37.5K ﹤0.01% 2191
2022
Q1
$290K Sell
528
-39
-7% -$23.6K ﹤0.01% 1784
2021
Q4
$375K Sell
567
-2
-0.4% -$1.53K ﹤0.01% 1715
2021
Q3
$477K Sell
569
-35
-6% -$35.5K ﹤0.01% 1604
2021
Q2
$766K Buy
604
+179
+42% +$202K 0.01% 1415
2021
Q1
$466K Buy
425
+16
+4% +$21.1K 0.02% 1024
2020
Q4
$584K Buy
409
+2
+0.5% +$2.13K 0.02% 873
2020
Q3
$287K Sell
407
-7
-2% -$5.09K 0.01% 1129
2020
Q2
$289K Buy
+414
New +$239K 0.01% 1126

Other funds holding CDLX

Amalgamated Bank's CDLX Position: Q2 2025 in Review

Amalgamated Bank sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 128 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in CDLX in Q2 2020 and held it in 20 quarters. The position peaked at $766K in Q2 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Amalgamated Bank reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 128 Cardlytics shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in Cardlytics in Q2 2020 and held it in 20 quarters.
  • Amalgamated Bank's Cardlytics position peaked at $766K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.